Cancer Vaccines

Cloned T9 cells protect against intracranial glioma tumors

Published in Cancer Weekly, October 22nd, 2002

by Maria G. Essig, MS, ELS, senior medical writer - Immunity against intracranial T9 gliomas was conferred by treatment of rats with live cloned T9-C2 glioma cells that expressed macrophage colony-stimulating factor (mM-CSF), according to a report by researchers from the U.S.

Yijun Chen and colleagues at the University of California-Irvine, and California State University and the Veterans Affairs Medical Center in Long Beach, found that control T9 glioma cells formed subcutaneous tumors in rats but cloned T9-C2 cells expressing mM-CSF or Bcl2 did not.

The mechanism of protection conferred by immunization using T9-C2 cells involved vacuolization of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-10-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry